育龄期妇女血清EFAs和NEFAs轮廓谱及其用于NTDs预防性营养干预研究

本文借助GC/MS代谢组学方法, 测定了育龄期妇女血清中酯化和非酯化脂肪酸轮廓谱, 并对营养干预前后育龄期妇女血清脂肪酸含量变化进行了研究. 按营养干预组(48例)和对照组(48例)分组, 测定了育龄期妇女血清中酯化脂肪酸(EFAs)和非酯化脂肪酸(NEFAs)的平均含量; 利用SIMCA-P软件对定量结果进行PLS-DA分析, 聚类结果良好. 基于定量结果, 指认了6种潜在营养生物标志物, 并由此初步探讨了这些潜在生物标志物的生理意义以及营养素干预对育龄期妇女血清脂肪酸含量的影响, 以及脂肪酸代谢变化可能对胚胎神经发育造成的影响.     

A new metabonomics method for simultaneous determination of EFAs and NEFAs in plasma using GC-MS and its application

A new metabonomics method was developed for simultaneous qualitative and quantitative analysis on esterified and nonesterified fatty acids(EFAs and NEFAs) in plasma.Merely 10μL of plasma was required.The pretreatment of the sample was simple without disposing the protein.After simple extraction and derivation,15 FAs in plasma were precisely quantified.Gas chromatography tandem mass spectrometry(GC-MS) was used in the study and the quantities of the analytes,which varied in abundance over three orders of ...     

Secondary metabolites of Pyricularia oryzae II. Polyketide metabolites

A number of exometabolites have been isolated from the deuteromycetePyricularia oryzae Cav., of which harman and O-demethyldiaporthin have been isolated from this species for the first time. The latter is the first example of a hexaketide from fungi of the genusPyricularia, for which only penta- and heptaketides have previously been described. All-Union Scientific-Research Institute of Phytopathology, Moscow. Translated from Khimiya Prirodnykh Soedinenii, No. 4, pp. 471–475, July–August, 1991.     

Secondary metabolites of Pyricularia oryzae II. Polyketide metabolites

A number of exometabolites have been isolated from the deuteromycetePyricularia oryzae Cav., of which harman and O-demethyldiaporthin have been isolated from this species for the first time. The latter is the first example of a hexaketide from fungi of the genusPyricularia, for which only penta- and heptaketides have previously been described.All-Union Scientific-Research Institute of Phytopathology, Moscow. Translated from Khimiya Prirodnykh Soedinenii, No. 4, pp. 471–475, July–August, 1991.     

The biosynthesis of shikimate metabolites

This review covers the literature published during 2000 on the biosynthesis of compounds derived wholly or partly from intermediates on the shikimate pathway. Recent developments in the enzymology and genetics of the shikimate pathway arc also described. Enzymes involved in the biogenetic pathway to the aromatic amino acids are covered initially followed by sections dedicated to metabolites derived in some part from intermediates on the pathway. These include pyrrolnitrin. violacein. indole-3-acetic acid, coumarins, lignans, lignin, tannins, melanin, flavanoids, ubiquinone, TOPA quinone, PQQ, and tropanes.     

Microbial metabolites of harman alkaloids

Several microorganisms showed the ability to transform the harman alkaloids, harmaline (1), harmalol (2) and harman (5). Harmaline (1) and harmalol (2) were converted by Rhodotorula rubra ATCC 20129 into the tryptamines, 2-acetyl-3-(2-acetamidoethyl)-7-methoxyindole (3) and 2-acetyl-3-(2-acetamidoethyl)-7-hydroxyindole (4), respectively. Harman (5) was biotransformed by Cunninghamella echinulata NRRL 3655 into 6-hydroxyharman (6) and harman-2-oxide (7).     

A global view of metabolites

Fungi are rich sources of medically useful, as well as toxic, secondary metabolites. In this issue of Chemistry & Biology, Bok et al. show that, in Aspergillus nidulans, microarray analysis and manipulation of a global regulator can identify novel metabolite genes.     

Antimalarial activity of plant metabolites

This review covers the structures of compounds with antiplasmodial activity isolated from plants and is organized according to plant family. A total of 170 structures has been reviewed from 186 references found in the literature up to December 2000.     

Chromatographic analysis of tryptophan metabolites

The kynurenine pathway generates multiple tryptophan metabolites called collectively kynurenines and leads to formation of the enzyme cofactor nicotinamide adenine dinucleotide. The first step in this pathway is tryptophan degradation, initiated by the rate‐limiting enzymes indoleamine 2,3‐dioxygenase, or tryptophan 2,3‐dioxygenase, depending on the tissue. The balanced kynurenine metabolism, which has been a subject of multiple studies in last decades, plays an important role in several physiological and pathological conditions such as infections, autoimmunity, neurological disorders, cancer, cataracts, as well as pregnancy. Understanding the regulation of tryptophan depletion provide novel diagnostic and treatment opportunities, however it requires reliable methods for quantification of kynurenines in biological samples with complex composition (body fluids, tissues, or cells). Trace concentrations, interference of sample components, and instability of some tryptophan metabolites need to be addressed using analytical methods. The novel separation approaches and optimized extraction protocols help to overcome difficulties in analyzing kynurenines within the complex tissue material. Recent developments in chromatography coupled with mass spectrometry provide new opportunity for quantification of tryptophan and its degradation products in various biological samples. In this review, we present current accomplishments in the chromatographic methodologies proposed for detection of tryptophan metabolites and provide a guide for choosing the optimal approach.